eli lilly tirzepatide shortage Lilly, Novo Fight Weight Loss Drug Compounders Over Eli Lilly sues companies selling

Beginning as early as April 1, 2026, both Zepbound and orforglipron will be offered to Medicare beneficiaries for $50 per month, if approved by the FDA.Further, states will be able to expand access to Zepbound and orforglipron through Medicaid

We explain what sports clubs and event organisers need to know about Martyns Law

With Methylene Blue for Antioxidant Support A next-generation antioxidant that helps support skin clarity and hydration ideal for daily skincare routines

NiceRx works with state-licensed compounding pharmacies that make compounded tirzepatide in compliance with state and federal laws

- Discontinue use and consult a doctor if any adverse reactions occur

Compounded versions have not undergone the same FDA review process, and their dosing accuracy, sterility, and potency cannot be independently verified